A detailed history of Cm Management, LLC transactions in Kronos Bio, Inc. stock. As of the latest transaction made, Cm Management, LLC holds 135,000 shares of KRON stock, worth $126,900. This represents 0.16% of its overall portfolio holdings.

Number of Shares
135,000
Previous 250,000 46.0%
Holding current value
$126,900
Previous $325,000 48.62%
% of portfolio
0.16%
Previous 0.28%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 01, 2024

SELL
$0.73 - $1.38 $83,950 - $158,700
-115,000 Reduced 46.0%
135,000 $167,000
Q2 2023

Aug 04, 2023

BUY
$1.24 - $1.92 $86,800 - $134,400
70,000 Added 38.89%
250,000 $430,000
Q1 2023

May 08, 2023

BUY
$1.34 - $2.62 $201,000 - $393,000
150,000 Added 500.0%
180,000 $263,000
Q4 2022

Feb 09, 2023

BUY
$1.44 - $3.44 $43,200 - $103,200
30,000 New
30,000 $49,000

Others Institutions Holding KRON

About Kronos Bio, Inc.


  • Ticker KRON
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,769,100
  • Market Cap $53.4M
  • Description
  • Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer therapeutics. The company's product engine focuses on dysregulated transcription factors and the transcriptional regulatory networks that drive oncogenic activity. Its lead product candidate is entospletinib (ENTO), is an orally...
More about KRON
Track This Portfolio

Track Cm Management, LLC Portfolio

Follow Cm Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cm Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cm Management, LLC with notifications on news.